Although type 2 diabetes patients’ resistance to the effects of betatrophin, cannot be ruled out, the results of this study revealed significant high level of betatrophin in the macroalbuminuric group as compared to the other two diabetic and control groups. This evidence concerns the gene ANGPTL8 and type 2 diabetes mellitus.